These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38135787)

  • 1. CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy.
    Gumusgoz E; Kasiri S; Verma M; Wu J; Villarreal Acha D; Marriam U; Fyffe-Maricich S; Lin A; Chen X; Gray SJ; Minassian BA
    Gene Ther; 2024 May; 31(5-6):234-241. PubMed ID: 38135787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression alterations in the cerebellum and granule neurons of Cstb(-/-) mouse are associated with early synaptic changes and inflammation.
    Joensuu T; Tegelberg S; Reinmaa E; Segerstråle M; Hakala P; Pehkonen H; Korpi ER; Tyynelä J; Taira T; Hovatta I; Kopra O; Lehesjoki AE
    PLoS One; 2014; 9(2):e89321. PubMed ID: 24586687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain inflammation is accompanied by peripheral inflammation in Cstb
    Okuneva O; Li Z; Körber I; Tegelberg S; Joensuu T; Tian L; Lehesjoki AE
    J Neuroinflammation; 2016 Nov; 13(1):298. PubMed ID: 27894304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epilepsy, the protease inhibitor and the dodecamer: progressive myoclonus epilepsy, cystatin b and a 12-mer repeat expansion.
    Lalioti MD; Antonarakis SE; Scott HS
    Cytogenet Genome Res; 2003; 100(1-4):213-23. PubMed ID: 14526183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1.
    Lalioti MD; Scott HS; Antonarakis SE
    Hum Mol Genet; 1999 Sep; 8(9):1791-8. PubMed ID: 10441345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cystatin B gene promoter harboring the dodecamer repeat expanded in progressive myoclonus epilepsy, EPM1.
    Alakurtti K; Virtaneva K; Joensuu T; Palvimo JJ; Lehesjoki AE
    Gene; 2000 Jan; 242(1-2):65-73. PubMed ID: 10721698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1.
    Okuneva O; Körber I; Li Z; Tian L; Joensuu T; Kopra O; Lehesjoki AE
    Glia; 2015 Mar; 63(3):400-11. PubMed ID: 25327891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
    de Haan GJ; Halley DJ; Deelen WH; Lindhout D
    Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations.
    Alakurtti K; Weber E; Rinne R; Theil G; de Haan GJ; Lindhout D; Salmikangas P; Saukko P; Lahtinen U; Lehesjoki AE
    Eur J Hum Genet; 2005 Feb; 13(2):208-15. PubMed ID: 15483648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1.
    Singh S; Hämäläinen RH
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In depth behavioral phenotyping unravels complex motor disturbances in
    Pollari E; Tegelberg S; Björklund H; Kälviäinen R; Lehesjoki AE; Haapalinna A
    Front Behav Neurosci; 2023; 17():1325051. PubMed ID: 38179183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-Expression Profiling Suggests Impaired Signaling via the Interferon Pathway in Cstb-/- Microglia.
    Körber I; Katayama S; Einarsdottir E; Krjutškov K; Hakala P; Kere J; Lehesjoki AE; Joensuu T
    PLoS One; 2016; 11(6):e0158195. PubMed ID: 27355630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.
    Lalioti MD; Scott HS; Buresi C; Rossier C; Bottani A; Morris MA; Malafosse A; Antonarakis SE
    Nature; 1997 Apr; 386(6627):847-51. PubMed ID: 9126745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence of a role for cystatin B gene in juvenile myoclonic epilepsy.
    Mumoli L; Tarantino P; Michelucci R; Bianchi A; Labate A; Franceschetti S; Marini C; Striano P; Gagliardi M; Ferlazzo E; Sofia V; Pennese L; Annesi G; Aguglia U; Guerrini R; Zara F; Gambardella A;
    Epilepsia; 2015 Apr; 56(4):e40-3. PubMed ID: 25752200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Changes in the Mitochondrial Proteome of Cerebellar Synaptosomes From Preclinical Cystatin B-Deficient Mice.
    Gorski K; Spoljaric A; Nyman TA; Kaila K; Battersby BJ; Lehesjoki AE
    Front Mol Neurosci; 2020; 13():570640. PubMed ID: 33281550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.
    Vaarmann A; Kaasik A; Zharkovsky A
    Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human induced pluripotent stem cell line (UEFi004-A) from a patient with progressive myoclonic epilepsy type 1 (EPM1).
    Singh S; Plotnikova L; Karvonen K; Ryytty S; Hyppönen J; Kälviäinen R; Hämäläinen RH
    Stem Cell Res; 2023 Dec; 73():103248. PubMed ID: 37951142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1.
    Tegelberg S; Kopra O; Joensuu T; Cooper JD; Lehesjoki AE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):40-53. PubMed ID: 22157618
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.